Ambit Biosciences Corp (NASDAQ:AMBI) Investor Alert: Acquisition Faces Investigation
The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of Ambit Biosciences Corp (NASDAQ:AMBI), was initiated concerning whether the takeover of Ambit Biosciences Corp. by Daiichi Sankyo Company for $15 per share is unfair to NASDAQ:AMBI stockholders.
View full press release